Suzhou
China
17
2023-08-24
15
2019-11-26
These are the the leading inventors for applications assigned to CRYSTAL PHARMATECH CO., LTD:
CRYSTAL PHARMATECH CO., LTD based in Suzhou, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
CRYSTALLINE FORMS OF BENZAMIDE COMPOUND AND PROCESS FOR PREPARING THE SAME
#2 | 2019-11-14 ✅ Patent 10,487,064 granted on 2019-11-26Crystalline forms of selective S1P1 receptor modulator and preparation method thereof
#3 | 2019-10-24 ✅ Patent 10,544,129 granted on 2020-01-28Crystalline forms of AP26113, and preparation method thereof
#4 | 2019-07-18 ✅ Patent 10,562,855 granted on 2020-02-18Crystalline form of lenvantinib mesylate and process of preparation thereof
#5 | 2019-04-25 ✅ Patent 10,577,334 granted on 2020-03-03Crystalline form E of tafamidis meglumine, process for preparation and use thereof
#6 | 2019-02-21 ✅ Patent 10,472,369 granted on 2019-11-12Crystalline forms of (6-(1H-indazol-6-yl)-N-[4-(4-(4-morpholinyl)phenyl]imidazo[1,2-A]pyrazin-8-amine) methanesulfonate
#7 | 2018-10-04 ✅ Patent 10,138,250 granted on 2018-11-27Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt
#8 | 2018-09-20 ✅ Patent 10,246,437 granted on 2019-04-02Crystal form of neratinib maleate and preparation method therefor
#9 | 2018-07-19 ✅ Patent 10,508,087 granted on 2019-12-17Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof
#10 | 2018-06-21 ✅ Patent 10,266,523 granted on 2019-04-23Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4′-(trifluoromethoxy) [1,1′-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof
#11 | 2018-03-29 ✅ Patent 10,233,144 granted on 2019-03-19Crystalline form of AHU377, preparation method and use thereof
#12 | 2018-03-15 ✅ Patent 10,196,395 granted on 2019-02-05Crystalline form alpha of IPI-145 and preparation method thereof
#13 | 2018-03-08 ✅ Patent 10,138,239 granted on 2018-11-27Preparation method of crystalline form a of PCI-32765
#14 | 2018-02-15 ✅ Patent 10,377,757 granted on 2019-08-13Crystal form of JAK inhibitor and preparation method thereof
#15 | 2017-11-30 ✅ Patent 9,994,579 granted on 2018-06-12Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt
#16 | 2016-10-13 ✅ Patent 10,351,536 granted on 2019-07-16Crystalline forms of lesinurad and its sodium salt
#17 | 2016-09-29CRYSTALLINE FORMS B, C, and D OF CANAGLIFLOZIN
Also check out CRYSTAL PHARMATECH CO., LTD.'s (Suzhou, China) applicant profile with 1 patent applications submitted.
113600 ⎘